Compare FOA & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOA | FOCL |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.6M | 203.7M |
| IPO Year | 2021 | 1998 |
| Metric | FOA | FOCL |
|---|---|---|
| Price | $17.16 | $4.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $26.00 | N/A |
| AVG Volume (30 Days) | 44.8K | ★ 187.3K |
| Earning Date | 05-05-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 216.95 | N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $497,432,000.00 | $70,527,000.00 |
| Revenue This Year | $0.58 | N/A |
| Revenue Next Year | $6.91 | N/A |
| P/E Ratio | $42.55 | ★ N/A |
| Revenue Growth | ★ 47.09 | 1.63 |
| 52 Week Low | $15.77 | $4.01 |
| 52 Week High | $29.79 | $6.40 |
| Indicator | FOA | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 26.89 | 32.77 |
| Support Level | $15.93 | $4.01 |
| Resistance Level | $20.17 | $4.50 |
| Average True Range (ATR) | 0.73 | 0.25 |
| MACD | -0.26 | -0.00 |
| Stochastic Oscillator | 7.61 | 25.31 |
Finance of America Companies Inc provides home equity-based financing solutions for modern retirement and offers capital markets and portfolio management capabilities to optimize loan distribution to investors. The Company operates through two segments: Retirement Solutions and Portfolio Management. The Retirement Solutions segment handles loan origination, including HECM and non-agency reverse mortgage loans, generating revenue from origination fees and initial gains, with loans transferred to the Portfolio Management segment. The Portfolio Management segment, which generates the majority of revenue, provides securitization, loan sales, risk management, and asset management services, and earns revenue from net interest income, fair value changes, and servicing-related income.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.